SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-098871
Filing Date
2022-04-07
Accepted
2022-04-07 16:08:54
Documents
8

Document Format Files

Seq Description Document Type Size
1 DEFA14A d320936ddefa14a.htm DEFA14A 27941
2 GRAPHIC g320936g01a00.jpg GRAPHIC 5745
3 GRAPHIC g320936g02a00.jpg GRAPHIC 2537
4 GRAPHIC g320936g03a00.jpg GRAPHIC 2590
5 GRAPHIC g320936g04a00.jpg GRAPHIC 1806
6 GRAPHIC g320936g05a00.jpg GRAPHIC 1602
7 GRAPHIC g320936g06a00.jpg GRAPHIC 2347
8 GRAPHIC g320936g07a00.jpg GRAPHIC 1891
  Complete submission text file 0001193125-22-098871.txt   55289
Mailing Address 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121
Business Address 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121 858-369-7800
Metacrine, Inc. (Filer) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39512 | Film No.: 22813945
SIC: 2834 Pharmaceutical Preparations